ライフサイエンスコーパス: intensive care

1 no children required respiratory support or intensive care.

2 ed supplemental oxygen; of these, 2 required intensive care.

3 itive residents were hospitalized, with 1 in intensive care.

4 evaluation II scores in patients admitted to intensive care.

5 correlate with requirements for admission or intensive care.

6 astinitis, were in need of a laparascopy and intensive care.

7 COVID-19, particularly in those who required intensive care.

8 was 6 days (IQR, 3-12 days) and 26% required intensive care.

9 ed, experience severe symptoms necessitating intensive care.

10 op severe disease and 5% of patients require intensive care(2).

11 monia diagnosis, 5% (95% CI, 3%-6%) required intensive care, 2% (95% CI, 1%-3%) included a sepsis dia

12 omes Sepsis patients, 60.8% were admitted to intensive care, 26.4% had new positive-pressure ventilat

13 range, 4 to 10); 148 patients (80%) received intensive care, 37 (20%) received mechanical ventilation

14 OVID-19 and access to health care (including intensive care) across ethnicities.

15 ger in-patient admission and higher rates of intensive care admission.

16 ories: pre-existing and those related to the intensive care admission.

17 VID-19 led to 1,832 hospital admissions, 207 intensive care admissions and 126 deaths.

18 f COVID-19 until March 10, 2020, and with no intensive care admissions or deaths until July 6, 2020.

19 Overall, 15% underwent intensive care and 32% developed recurrent wheeze by age

20 could permit early institution of aggressive intensive care and antiviral and immune treatment to red

21 Nurses had a crucial role in providing intensive care and assisting with activities of daily li

22 ferential mortality and neurologic injury in intensive care and cardiac arrest patients; however, few

23 d multidimensional symptoms extending beyond intensive care and hospital discharge.

24 effectiveness of early rehabilitation in the intensive care and marked variation in rates of implemen

25 ) and 1.37 (95% CI: 1.03-2.11) for requiring intensive care and mechanical ventilation, respectively.

26 ays on mechanical ventilation, and length of intensive care and total hospital stay, although the lac

27 subset of patients (only patients requiring intensive care and/or patients with septic shock), blend

28 total of 976 (24%) patients were admitted to intensive care, and 745 (76%) experienced AKI.

29 en are more likely to be hospitalized, enter intensive care, and die than women.

30 ection is a current clinical need to improve intensive care-applied therapies applied to critically i

31 data as a quality indicator or benchmark in intensive care can only meaningfully be interpreted if e

32 comorbidities, limited hospitalization, and intensive care capacity may increase this risk; thus, we

33 ed in 89.4% of patients with COVID-19 in the intensive care cohort and 84.7% of those in the hospital

34 ng characteristic curves were lower than the Intensive Care Delirium Screening Checklist (standard of

35 Confusion Assessment Method for the ICU and Intensive Care Delirium Screening Checklist against refe

36 sion Assessment Method and Sour Seven to the Intensive Care Delirium Screening Checklist and Confusio

37 accuracy than clinical assessments using the Intensive Care Delirium Screening Checklist and Confusio

38 Since the Intensive Care Delirium Screening Checklist may be posit

39 ion Assessment Method or Sour Seven with the Intensive Care Delirium Screening Checklist or Confusion

40 er, or worse for some combinations, than the Intensive Care Delirium Screening Checklist or Confusion

41 The Intensive Care Delirium Screening Checklist's inclusion

42 the Confusion Assessment Method for the ICU, Intensive Care Delirium Screening Checklist, a focused b

43 Medical-surgical intensive care department of two university hospitals in

44 of end-stage liver disease may warrant more intensive care during endoscopic procedures, including a

45 en requires multidisciplinary management and intensive care, during which allergists and immunologist

46 e expanded in recent decades to include more intensive care for increasingly precarious patients with

47 multiorgan dysfunction frequently requiring intensive care has been observed after severe acute resp

48 heart failure hospitalizations that required intensive care (HR, 0.67; 95% CI, 0.50-0.90; P=0.008) an

49 in four children and adolescents admitted to intensive care in April 2020 for multisystem inflammator

50 suggest high mortality and low admission to intensive care in patients with thoracic cancer.

51 Seventeen patients (61%) required intensive care, including 7 patients (25%) who required

52 acteristics of infected patients who require intensive care is limited.

53 the likelihood of severe illness (defined as intensive care, mechanical ventilation, or death) among

54 Despite recent advances in intensive care medicine, the mortality is still as high

55 al Care Medicine and the European Society of Intensive Care Medicine.

56 BS patients were more frequently admitted to intensive care, mortality was not increased versus contr

57 e total cohort was analyzed by site of care: intensive care (n = 170); hospitalized nonintensive care

58 The Intensive Care National Audit and Research Centre Case M

59 hysicians with expertise in HSCT, paediatric intensive care, nephrology, hepatology, radiology, patho

60 ed hospitalized patients who did not receive intensive care (non-ICU).Measurements and Main Results:

61 s outpatients, 28 required admission without intensive care or ventilation, 13 required noninvasive v

62 We used a large dataset of intensive-care patient data to derive 126 decision rules

63 diagnose invasive fungal disease in COVID-19 intensive care patients.

64 Four clinician groups (intensive care physicians, nurses, therapists, and respi

65 s without biliary prosthesis who do not need intensive care, piperacillin/tazobactam represents a reg

66 mortality could be reduced with treatment in intensive care remains to be determined.

67 ion regarding the optimal management in many intensive care scenarios.

68 in patients with COVID-19, especially in the intensive care setting, despite a high utilization rate

69 accessed from the Australian and New Zealand Intensive Care Society Adult Patient Database between 20

70 a submitted to the Australia and New Zealand Intensive Care Society.

71 d involve a multidisciplinary team including intensive care specialists, infectious disease specialis

72 and biochemical parameters and the need for intensive care support (P<0.05).

73 ction had more aggressive disease, requiring intensive care support and longer hospital stays, than t

74 vated inflammatory markers, and the need for intensive care support.

75 s identified the defining attributes of post-intensive care syndrome as: (1) new or worsening multidi

76 Post-intensive care syndrome is a term used to describe new o

77 tive and qualitative studies related to post-intensive care syndrome published in English between 201

78 In the light of the relevance of post-intensive care syndrome-family in daily ICU care, more h

79 vision of information seems pivotal for post-intensive care syndrome-family treatment.

80 review randomized controlled trials for post-intensive care syndrome-family.

81 This was previously referred to as post-intensive care syndrome-family.

82 mprove symptoms or reduce prevalence of post-intensive care syndrome-family.

83 We recommend serial assessments for post-intensive care syndrome-related problems continue within

84 ls are insufficient to reliably predict post-intensive care syndrome.

85 therefore was to define the concept of post-intensive care syndrome.

86 ents with treatment-limiting POLSTs received intensive care that was potentially discordant with thei

87 c events delaying the initiation of targeted intensive care therapy.

88 ade surgeries but none required escalated or intensive care treatment related to COVID infection.

89 ls (60.3% vs 39.7%), from facilities without intensive care unit (46.9% vs 22.4%) or interventional r

90 Cardiac intensive care unit (CICU) patients <=18 years of age me

91 ss the spectrum of shock severity in cardiac intensive care unit (CICU) patients.

92 ays in the hospital (5 vs 15.5 days), in the intensive care unit (ICU) (4 vs 12 days), and on mechani

93 Mortality (22% vs 17%, P > .05) and intensive care unit (ICU) admission (26% vs 12%, P > .05

94 n for predicting patient outcome in terms of intensive care unit (ICU) admission (AUC: 0.75 vs 0.68)

95 R], 1.03 per year of increase; P = .001) and intensive care unit (ICU) admission (OR, 17.3; P < .001)

96 ll-cause death, severe Covid-19 diagnosis or intensive care unit (ICU) admission for men versus women

97 Limited data exist on predictors of intensive care unit (ICU) admission in patients with hem

98 Adverse outcome was defined as intensive care unit (ICU) admission or death.

99 nfirmed COVID-19 diagnosis, hospitalization, intensive care unit (ICU) admission, and death.

100 tal mortality, need for ventilatory support, intensive care unit (ICU) admission, and length of stay.

101 were more likely to be hospitalized, require intensive care unit (ICU) admission, and receive oxygen

102 outcome, defined as a composite endpoint of intensive care unit (ICU) admission, mechanical ventilat

103 We assessed hospitalization risk, intensive care unit (ICU) admission, need for oxygen sup

104 patients after a median of 4 (2-8) days from intensive care unit (ICU) admission.

105 ng 2 cases of megacolon, 1 colectomy, and 22 intensive care unit (ICU) admissions.

106 cterized by prolonged duration of stay in an intensive care unit (ICU) and increased number of leukoc

107 Hospital inpatient and intensive care unit (ICU) bed shortfalls may arise due t

108 60-day period, analyzed for their effects on intensive care unit (ICU) demand and death rate, and com

109 ments in terms of mortality and hospital and intensive care unit (ICU) discharge rates.

110 age <35 years) brother pairs admitted to the intensive care unit (ICU) due to severe COVID-19.

111 Patients admitted to the intensive care unit (ICU) for COVID-19-related acute res

112 at least 1 domain following admission to an intensive care unit (ICU) for respiratory or cardiovascu

113 9.9 days, p = 0.028) and shorter duration of intensive care unit (ICU) length of stay (LOS) prior to

114 are undergoing mechanical ventilation in the intensive care unit (ICU) often receive a high fraction

115 rmed COVID-19 were identified in the medical intensive care unit (ICU) or a specialised non-ICU COVID

116 (n = 200) from emergency department (ED) and intensive care unit (ICU) patients at a tertiary care ac

117 er number of perforin-expressing NK cells in intensive care unit (ICU) patients compared with non-ICU

118 Intensive care unit (ICU) patients or patients requiring

119 Vasopressors are commonly administered to intensive care unit (ICU) patients to raise blood pressu

120 We assayed EBV from the plasma of intensive care unit (ICU) patients with sepsis due to co

121 sociated infections (HAIs), particularly for intensive care unit (ICU) patients.

122 placement therapy (CRRT) represent a growing intensive care unit (ICU) population.

123 r pediatric resident physicians during their intensive care unit (ICU) rotations: extended-duration w

124 s, or hospitalization >24 hours), or severe (intensive care unit (ICU) stay for >24 hours, septic sho

125 ior studies of patient survivorship after an intensive care unit (ICU) stay suggest that many critica

126 markers for disease severity, e.g. requiring intensive care unit (ICU) treatment, remain poorly defin

127 first 10 days in relation to their need for intensive care unit (ICU) treatment.

128 ttle-area hospitals who were admitted to the intensive care unit (ICU) with confirmed infection with

129 perglycaemia is one such complication in the intensive care unit (ICU), accompanied by decades of con

130 first extubation, time to discharge from the intensive care unit (ICU), and 1-year survival.

131 endpoint of escalation of care from ward to intensive care unit (ICU), new requirement for mechanica

132 The national impact on intensive care unit (ICU)-acquired infections has not be

133 tive disease incidence and mortality, and on intensive care unit (ICU)-bed occupancy.

134 oeconomic and clinical risk factors for post-intensive care unit (ICU)-related long-term cognitive im

135 n due to the lack of an available bed in the intensive care unit (ICU).

136 on ventilation and the length of stay in the intensive care unit (ICU).

137 tient management, with 7 (50%) placed in the intensive care unit (ICU).

138 ne profile of critically ill patients in the intensive care unit (ICU).

139 pitalized and 26.8% (n = 30) admitted to the intensive care unit (ICU).

140 nts as stress ulcer prophylaxis drugs in the intensive care unit (ICU).

141 that aimed to optimize BCx use in a medical intensive care unit (MICU) and five medicine units at a

142 Mothers with babies in the neonatal intensive care unit (NICU) face a host of challenges fol

143 h within 7 days or admission to the neonatal intensive care unit (NICU) with moderate-to-severe hypox

144 h care-associated infections in the neonatal intensive care unit (NICU).

145 The risk of admission to the intensive care unit (RR, 3.9; 95% CI, 3.4-4.5), need for

146 d critically unwell patients admitted to the intensive care unit [ICU; n=5]).

147 eters and CT metrics versus patient outcome (intensive care unit [ICU] admission or death vs no ICU a

148 care, and hospital outcomes (length of stay, intensive care unit [ICU] admission, mechanical ventilat

149 d hospitalization outcomes (severe COVID-19, intensive care unit [ICU] admission, mechanical ventilat

150 757 (15.5%) included UAT performed (18.4% of intensive care unit [ICU] and 15.3% of non-ICU patients)

151 its did not decrease significantly (surgical intensive care unit [ICU], P = 0.06; surgical units, P =

152 had similar rates of admission (89% vs 90%), intensive care unit admission (35% vs 36%), intubation (

153 e clinical course, including higher rates of intensive care unit admission (69%), intubation (65%), r

154 Ninety percent of patients required intensive care unit admission and 39% were intubated.

155 performed in patients upon hospital ward or intensive care unit admission and in healthy controls (n

156 nd the log-rank test, we compared morbidity (intensive care unit admission and intubation) and mortal

157 fibrillation and delirium occurring between intensive care unit admission and the earlier of postope

158 nt of CT lung abnormality were predictors of intensive care unit admission or death.

159 Intensive care unit admission was required for 27 patien

160 o predict critical illness (ie, death and/or intensive care unit admission with invasive ventilation)

161 tcomes attributable to CDI, including death, intensive care unit admission, and colectomy, were obser

162 hree groups: routine inward hospitalization, intensive care unit admission, and deceased based on a s

163 genital heart disease, chronic lung disease, intensive care unit admission, and ventilator use) were

164 advanced medical outcomes (hospitalization, intensive care unit admission, intubated mechanical vent

165 advanced medical outcomes (hospitalization, intensive care unit admission, intubated mechanical vent

166 primary outcome was clinical deterioration (intensive care unit admission, invasive mechanical venti

167 site adverse clinical outcome of intubation, intensive care unit admission, or death.

168 need for vasopressor, incidence of unplanned intensive care unit admission, rate of need for rapid re

169 tion, blood was collected within 72 hours of intensive care unit admission.

170 a median of 2 days (Q1, Q3: 1, 3 days) from intensive care unit admission.

171 Intensive care unit admissions increased for RSVH (from

172 o experience high rates of hospitalizations, intensive care unit admissions, and in-hospital deaths a

173 -related mortality; length of hospital stay; intensive care unit admissions; acute graft-versus-host

174 y outcomes included duration of ventilation, intensive care unit and hospital length of stay, 3-month

175 hospital mortality was 19.0%, and the median intensive care unit and hospital lengths of stay were 2.

176 s within 14 days after surgery, durations of intensive care unit and hospital stays, and all-cause mo

177 t to critically ill patients confined to the intensive care unit and is characterized by colonization

178 blood products donated, limited space in the intensive care unit and the duty to maintain safety and

179 in vegetative state, was transferred to the intensive care unit and then to the Health and Care Cent

180 ntly more likely to have been admitted to an intensive care unit and to have received an intensive pr

181 on use and intensive treatment (admission to intensive care unit and/or positive pressure ventilation

182 This study used bed availability in the intensive care unit as an instrument for admission to th

183 irus disease 2019 (COVID-19) admitted to the intensive care unit at a public hospital in Washington S

184 atient-level data including mortality rates, intensive care unit bed days, and ventilator days from i

185 d to the fraught question of how to allocate intensive care unit beds and mechanical ventilators if t

186 triage of patients to the limited number of intensive care unit beds or facilities.

187 ts with DoC and that detection of CMD in the intensive care unit can predict functional recovery at 1

188 He did not require intensive care unit care or ventilation.

189 R, 56-78]; 33.5% female) were treated in the intensive care unit care, 320 (12.2%) received invasive

190 uded family appreciation and a collaborative intensive care unit culture committed to dignity-conserv

191 l fractures were assessed at baseline (after intensive care unit discharge) and at 6 and 12 months.

192 The 68-year-old male was admitted to the intensive care unit due to severe community acquired pne

193 The combined intensive care unit group and deceased patients had sign

194 surgery and at the time of admission to the intensive care unit in critically ill patients.

195 dult patients with SD admitted to a tertiary intensive care unit in Malaysia.

196 lations were performed at the bedside in the intensive care unit in patients who had undergone a tria

197 ed early antibiotic exposure in the neonatal intensive care unit is associated with an increased risk

198 day mortality (7.1% vs 2.9%), shorter median intensive care unit length of stay (2 days vs 1 day) and

199 (in-hospital death, hospital length of stay, intensive care unit length of stay, and ventilator days)

200 , rate of need for rapid response team call, intensive care unit length of stay, hospital length of s

201 in donor selection (age, cold ischemia time, intensive care unit length, amylase concentration), panc

202 erences in handgrip strength, delirium rate, intensive care unit mortality, hospital mortality, and p

203 diagnosis of aSAH admitted to the neurologic intensive care unit of a regional referral hospital over

204 The primary end point was admission to the intensive care unit or death during hospitalization, and

205 severe disease, defined as admission to the intensive care unit or death.

206 creening examinations at a level IV neonatal intensive care unit over a 7-year period.

207 n stool swab samples collected from neonatal intensive care unit patients within 7 days of discontinu

208 ess, appropriateness of empiric antibiotics, intensive care unit placement, tracheostomy dependence,

209 Covid-19 intensive care unit staff were relatively protected (0.4

210 uration of mechanical ventilation, length of intensive care unit stay and hospital stay.

211 ively predicting trauma patients who require intensive care unit stays longer than 5 days with ongoin

212 nfection, 11 had been hospitalized (3 in the intensive care unit) and 15 had died (mortality, 26%).

213 f mechanical ventilation and/or admission to intensive care unit) and development of recurrent wheeze

214 these 186 patients, 27% were admitted to the intensive care unit, 48% were immunocompromised, and 45%

215 ospital-acquired pneumonia (HAP) outside the intensive care unit, 61% were treated empirically withou

216 epresented an ill population with 69% in the intensive care unit, 63% mechanically ventilated, and 42

217 required admission, with 18 admitted to the intensive care unit, and 13 requiring intubation.

218 ence of myocarditis, 80% were admitted to an intensive care unit, and 2 died.

219 Thirty patients were admitted to the intensive care unit, and 30 patients died during the hos

220 hose hospitalized, 47.5% were admitted to an intensive care unit, and 6.2% died during hospitalizatio

221 r life-threatening COVID-19, with 66% in the intensive care unit, as part of the US FDA expanded acce

222 ury prevention methods in place, being in an intensive care unit, being in a smaller hospital, and be

223 ation with worse outcomes in patients in the intensive care unit, discuss potential biologically plau

224 sociation was noted between VL, admission to intensive care unit, length of oxygen support, and overa

225 stics and outcomes (length of stay, need for intensive care unit, mechanical ventilation, and in-hosp

226 Primary composite outcome (escalation to intensive care unit, mechanical ventilation, or in-hospi

227 ure or arrhythmias requiring admission to an intensive care unit, myocardial infarction, stroke, aort

228 outcome, defined as: death, admission to an intensive care unit, or decision to withdraw or withhold

229 cohort of COVID-19 patients admitted to the intensive care unit, platelet-monocyte interaction was s

230 Among patients hospitalized in the intensive care unit, the case fatality is up to 40%.

231 espite the growing use of RRT in the cardiac intensive care unit, there are few resources for the car

232 e rehabilitation of patients admitted to the intensive care unit, with a proven benefit for criticall

233 spitalized patients require admission to the intensive care unit, with the majority of those requirin

234 A case study focusing on intensive care unit-acquired bacteremia using data from

235 arch Council score; reduced the incidence of intensive care unit-acquired weakness and intensive care

236 of intensive care unit-acquired weakness and intensive care unit-related complications such as ventil

237 ytotoxic lesions of the corpus callosum, and intensive care unit-related complications, we identified

238 act treatment of up to 4% of children in the intensive care unit.

239 %; 37/50) were critically ill and treated on intensive care unit.

240 hospitalized, 20 (40.8%) were admitted to an intensive care unit.

241 in the 25 of 35 of those discharged from the intensive care unit.

242 ventilator support and 18% were admitted to intensive care unit.

243 e unit as an instrument for admission to the intensive care unit.

244 dings during the baby's stay in the Neonatal Intensive Care Unit.

245 % were >=65 years old, and 66.1% were in the intensive care unit.

246 bility the patient was admitted to the local Intensive Care Unit.

247 % Hispanic/Latinx; 23.4% Black; 20.1% in the intensive care unit; 46.8% receiving supplemental oxygen

248 presentation and a higher admission rate in intensive care units (20 of 20 patients [100%] vs 12 of

249 more often on general medicine wards than in intensive care units (46% versus 33%; 19% versus 60% in

250 r disease are frequently admitted to cardiac intensive care units (CICUs), where care is commensurate

251 Patients in the intensive care units (ICU) had significantly higher CEC

252 , we investigated DNR orders on admission to intensive care units (ICUs) among 106,873 patients in th

253 tically ill adults with COVID-19 admitted to intensive care units (ICUs) at 67 hospitals across the U

254 th laboratory-confirmed COVID-19 admitted to intensive care units (ICUs) at 68 hospitals across the U

255 cquired bacteremia using data from 2 general intensive care units (ICUs) from 2 London teaching hospi

256 Extensive monitoring in intensive care units (ICUs) generates large quantities o

257 , open-label, clinical trial conducted in 41 intensive care units (ICUs) in Brazil.

258 er 26, 2017, through December 17, 2019, in 8 intensive care units (ICUs) in the Netherlands among 980

259 Hospital beds, intensive care units (ICUs), and ventilators are vital f

260 In five intensive care units (ICUs), we enrolled conscious, crit

261 cing recently became feasible for infants in intensive care units (ICUs).

262 common procedure for patients especially in intensive care units (ICUs).

263 infants with diseases of unknown etiology in intensive care units (ICUs).

264 for can improve the outcomes of patients in intensive care units (ICUs).

265 le for sepsis in preterm infants in neonatal intensive care units (NICUs) worldwide.

266 an 2,000 patient samples were collected from intensive care units across nine hospitals and tested fo

267 id clinical deterioration, prolonged stay in intensive care units and high risk for mortality correla

268 ificant differences with respect to stays in intensive care units and hospitals.

269 Two equivalent "Level III" neonatal intensive care units at the University Hospital Vienna,

270 ) which is currently a growing challenge for intensive care units due to the outbreak of the COVID-19

271 a in children who were admitted to pediatric intensive care units in 14 centers for cardiogenic shock

272 -blind, parallel-group trial conducted at 74 intensive care units in 8 European countries (December 2

273 trial conducted in 36 level III/IV neonatal intensive care units in Europe among 1013 infants with b

274 antisepsis of healthcare workers in neonatal intensive care units may be associated with long working

275 We included primary research in adult intensive care units regardless of patients' length of s

276 is difficult to predict, and the capacity of intensive care units was a limiting factor during the pe

277 established, elective care was postponed and Intensive Care Units were augmented with equipment and m

278 r oxygen administration, 18 were admitted to intensive care units, 12 required invasive ventilation,

279 34% were female; and 57% were from neonatal intensive care units, 33% were from pediatric intensive

280 Most patients were hospitalized, 12.1% in intensive care units, and 17.6% needed ventilator suppor

281 ntensive care units, 33% were from pediatric intensive care units, and 9% were from other hospital wa

282 s the incidence of bloodstream infections in intensive care units, but its effect has been understudi

283 roblem that threatens patients' treatment in intensive care units, causing thousands of deaths and a

284 d family-centered care intervention in adult intensive care units, with limited evidence on the impac

285 cally ill patients with COVID-19 from 208 UK intensive care units.

286 dure severely limits its application outside intensive care units.

287 stress syndrome requiring prolonged stays in intensive care units.

288 igh morbidity among patients discharged from intensive care units.

289 ections represent a major burden in neonatal intensive care units.

290 COVID-19, especially in patients admitted to intensive care units.

291 ators to implement family-centered rounds in intensive care units.

292 ken drastic measures to avoid an overflow of intensive care units.

293 dard clinical care in neonatal and pediatric intensive-care units (NICUs and PICUs, respectively) inv

294 associated with significantly lower risk of intensive care use (OR for each one-log increment, 0.39;

295 talization and examined its association with intensive care use (use of mechanical ventilation and/or

296 itis contributes to substantial acute (e.g., intensive care use) and chronic (e.g., recurrent wheeze

297 Intensive care was maintained for 48 h; aEEG was acquire

298 Intensive care was more likely among IC patients 65-79 y

299 Wuhan, China, and 40 (69%) of 58 patients in intensive care with COVID-19 in France.

300 e most common cause of death for patients in intensive care worldwide due to a dysregulated host resp